Allo-hematopoietic cell transplantation for Ph chromosome-positive ALL: impact of imatinib on relapse and survival (Q46382769)

21 December 2017

title

Allo-hematopoietic cell transplantation for Ph chromosome-positive ALL: impact of imatinib on relapse and survival (English)

1 reference

21 December 2017

1 reference

4

K S Baker

1 reference

21 December 2017

author name string

M J Burke

1

1 reference

21 December 2017

B Trotz

2

1 reference

21 December 2017

X Luo

3

1 reference

21 December 2017

D J Weisdorf

5

1 reference

21 December 2017

J E Wagner

6

1 reference

21 December 2017

M R Verneris

7

1 reference

21 December 2017

language of work or name

English

0 references

publication date

8 September 2008

1 reference

21 December 2017

Bone Marrow Transplantation

published in

1 reference

21 December 2017

volume

43

1 reference

21 December 2017

page(s)

107-113

1 reference

21 December 2017

issue

2

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1038/bmt.2008.296

exact match

0 references

cites work

Treatment of acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.296

The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.296

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.296

High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.296

Cardiac morbidity in advanced chronic myelogenous leukaemia patients treated by successive allogeneic stem cell transplantation with busulphan/cyclophosphamide conditioning after imatinib mesylate administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.296

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.296

Cardiotoxicity of the cancer therapeutic agent imatinib mesylate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.296

Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.296

Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.296

Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.296

Safety and efficacy of STI-571 (imatinib mesylate) in patients with bcr/abl-positive chronic myelogenous leukemia (CML) after autologous peripheral blood stem cell transplantation (PBSCT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.296

Congestive heart failure is a rare event in patients receiving imatinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.296

Acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.296

7 January 2021

Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.296

7 January 2021

Allogeneic bone marrow transplantation vs chemotherapy for children with Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.296

7 January 2021

Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.296

7 January 2021

Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.296

7 January 2021

Philadelphia chromosome-positive acute lymphoblastic leukemia in children: durable responses to chemotherapy associated with low initial white blood cell counts

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.296

7 January 2021

Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.296

7 January 2021

Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.296

7 January 2021

Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.296

7 January 2021

Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.296

7 January 2021

Identifiers

DOI

10.1038/BMT.2008.296

1 reference

21 December 2017

release_7groeovqc5fnjfjkr3x7ggeoba

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7groeovqc5fnjfjkr3x7ggeoba

24 November 2022

mapped directly with Wikidata item

PubMed ID

18776928

1 reference

21 December 2017